Mobile

An open-label, non-randomized pharmacokinetic and safety study of repeat doses of fluticasone furoate and GW642444M combination in healthy subjects and in subjects with severe renal impairment

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-020826-17

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

• To investigate the effect of severe renal impairment on the pharmacokinetics of FF and GW642444 following repeat administration of FF/ GW642444M (200/25mcg)via NDPI

Critère d'inclusion

  • Healthy subjects vs subjects with asthma or COPD

Liens